Pharmanutra S.p.A. (BIT:PHN)
Italy
· Delayed Price · Currency is EUR 79.10
+0.40 (0.51%)
Apr 28, 2026, 5:35 PM CET
Pharmanutra Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 20 | 16.61 | 12.83 | 15.05 | 13.77 | Upgrade
|
| Depreciation & Amortization | 3.2 | 3.51 | 2.42 | 1.15 | 1.01 | Upgrade
|
| Other Amortization | 0.22 | - | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 0.16 | 0.14 | 0.21 | 0.17 | 0.15 | Upgrade
|
| Other Operating Activities | 1.45 | 1.25 | 1.41 | 0.81 | 1.26 | Upgrade
|
| Change in Accounts Receivable | -2.87 | -2.98 | 2.22 | -5.15 | -1.77 | Upgrade
|
| Change in Inventory | -1.91 | 1.22 | -2.91 | -2.4 | -0.97 | Upgrade
|
| Change in Accounts Payable | 4.1 | 1.43 | -0.78 | 7.14 | 2.58 | Upgrade
|
| Change in Income Taxes | -1.3 | 0.02 | 2.55 | -3.04 | 3.59 | Upgrade
|
| Change in Other Net Operating Assets | -3.39 | -0.72 | -5.87 | 3.74 | 0.81 | Upgrade
|
| Operating Cash Flow | 19.56 | 20.42 | 12.09 | 17.47 | 20.41 | Upgrade
|
| Operating Cash Flow Growth | -4.22% | 68.91% | -30.77% | -14.44% | 73.02% | Upgrade
|
| Capital Expenditures | -3.13 | -4.25 | -13.25 | -26.16 | -4.99 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.66 | 0.55 | 0.27 | 0.08 | Upgrade
|
| Investment in Securities | - | - | - | 0.25 | - | Upgrade
|
| Other Investing Activities | -0.25 | 1.38 | -2.01 | -1.08 | -0.64 | Upgrade
|
| Investing Cash Flow | -3.36 | -2.21 | -14.7 | -26.72 | -5.54 | Upgrade
|
| Long-Term Debt Issued | 2.56 | 0.62 | 10.99 | 15.41 | 5.41 | Upgrade
|
| Total Debt Issued | 2.56 | 0.62 | 10.99 | 15.41 | 5.41 | Upgrade
|
| Long-Term Debt Repaid | -6.32 | -6.11 | -0.7 | -4.04 | -0.72 | Upgrade
|
| Total Debt Repaid | -6.32 | -6.11 | -0.7 | -4.04 | -0.72 | Upgrade
|
| Net Debt Issued (Repaid) | -3.76 | -5.49 | 10.29 | 11.38 | 4.69 | Upgrade
|
| Repurchase of Common Stock | -1.33 | -0.55 | -1.65 | -2.36 | - | Upgrade
|
| Common Dividends Paid | -9.59 | -8.17 | -7.71 | -6.85 | -6.49 | Upgrade
|
| Other Financing Activities | 1.56 | -7.38 | -1.44 | -0.27 | -0.12 | Upgrade
|
| Financing Cash Flow | -13.12 | -21.6 | -0.52 | 1.89 | -1.92 | Upgrade
|
| Net Cash Flow | 3.08 | -3.39 | -3.13 | -7.36 | 12.95 | Upgrade
|
| Free Cash Flow | 16.43 | 16.17 | -1.16 | -8.69 | 15.43 | Upgrade
|
| Free Cash Flow Growth | 1.59% | - | - | - | 52.49% | Upgrade
|
| Free Cash Flow Margin | 12.43% | 13.92% | -1.15% | -10.46% | 22.64% | Upgrade
|
| Free Cash Flow Per Share | 1.71 | 1.68 | -0.12 | -0.90 | 1.59 | Upgrade
|
| Levered Free Cash Flow | 15.2 | 12.74 | 2.25 | -14.67 | 11.35 | Upgrade
|
| Unlevered Free Cash Flow | 15.61 | 13.4 | 2.75 | -14.63 | 11.36 | Upgrade
|
| Change in Working Capital | -5.37 | -1.03 | -4.78 | 0.29 | 4.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.